PET imaging of amyloid with Florbetapir F 18 and PET imaging of dopamine degeneration with (18)F-AV-133 (florbenazine) in patients with Alzheimer’s disease and Lewy body disorders

BACKGROUND: Biomarkers based on the underlying pathology of Alzheimer’s disease (AD) and Dementia with Lewy Bodies (DLB) have the potential to improve diagnosis and understanding of the substrate for cognitive impairment in these disorders. The objective of this study was to compare the patterns of...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Siderowf, Andrew, Pontecorvo, Michael J, Shill, Holly A, Mintun, Mark A, Arora, Anupa, Joshi, Abhinay D, Lu, Ming, Adler, Charles H, Galasko, Douglas, Liebsack, Carolyn, Skovronsky, Daniel M, Sabbagh, Marwan N
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2014
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4027995/
https://ncbi.nlm.nih.gov/pubmed/24716655
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2377-14-79
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars